Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine

Bibliographic Details
Main Authors:	Jose W. Ricardo, MD, Shari R. Lipner, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	JAAD Case Reports
Subjects:	adverse reaction Beau lines COVID-19 nail psoriasis nails onycholysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512621006433

id	doaj-fa6f34f66f3a4b9699aadca29a9062f7
record_format	Article
spelling	doaj-fa6f34f66f3a4b9699aadca29a9062f72021-10-05T04:19:58ZengElsevierJAAD Case Reports2352-51262021-11-01171820Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccineJose W. Ricardo, MD0Shari R. Lipner, MD, PhD1Department of Dermatology, Weill Cornell Medicine, New York, New YorkCorrespondence to: Shari R. Lipner, MD, PhD, Department of Dermatology, Weill Cornell Medicine, 1305 York Avenue, New York, NY 10021.; Department of Dermatology, Weill Cornell Medicine, New York, New Yorkhttp://www.sciencedirect.com/science/article/pii/S2352512621006433adverse reactionBeau linesCOVID-19nail psoriasisnailsonycholysis
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Jose W. Ricardo, MD Shari R. Lipner, MD, PhD
spellingShingle	Jose W. Ricardo, MD Shari R. Lipner, MD, PhD Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine JAAD Case Reports adverse reaction Beau lines COVID-19 nail psoriasis nails onycholysis
author_facet	Jose W. Ricardo, MD Shari R. Lipner, MD, PhD
author_sort	Jose W. Ricardo, MD
title	Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_short	Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_full	Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_fullStr	Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_full_unstemmed	Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_sort	case of de novo nail psoriasis triggered by the second dose of pfizer-biontech bnt162b2 covid-19 messenger rna vaccine
publisher	Elsevier
series	JAAD Case Reports
issn	2352-5126
publishDate	2021-11-01
topic	adverse reaction Beau lines COVID-19 nail psoriasis nails onycholysis
url	http://www.sciencedirect.com/science/article/pii/S2352512621006433
work_keys_str_mv	AT josewricardomd caseofdenovonailpsoriasistriggeredbytheseconddoseofpfizerbiontechbnt162b2covid19messengerrnavaccine AT sharirlipnermdphd caseofdenovonailpsoriasistriggeredbytheseconddoseofpfizerbiontechbnt162b2covid19messengerrnavaccine
_version_	1716843625383460864

Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine

Similar Items